Inventor · disambiguated record
Daniel C. Javitt
Also filed as: JAVITT DANIEL · JAVITT DANIEL C
24 granted patents·19 pending applications·176 citations·filing 1996–2025
94Inventor score
Top patents by PatentIndex Score
43 records- 0195US9486453B2Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2015·Granted Nov 8, 2016·28 cites·6 claims
- 0290US10881665B2Formulations for treatment of post-traumatic stress disorderGLYTECH LLC·Filed 2018·Granted Jan 5, 2021·7 cites·10 claims
- 0387US5837730ATreatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonistsFiled 1996·Granted Nov 17, 1998·60 cites·12 claims
- 0478US12005035B1Compositions and methods for treatment of chronic pain and depressionJAVITT DANIEL C·Filed 2023·Granted Jun 11, 2024·0 cites·20 claims
- 0575US2025057788A1Compositions and methods for treatment of chronic pain and depressionJAVITT DANIEL C·Filed 2024·Application pending·0 cites
- 0675US2023201193A1Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2023·Application pending·0 cites
- 0774US11311193B2System, method and computer-accessible medium for predicting response to electroconvulsive therapy based on brain functional connectivity patternsUNIV COLUMBIA·Filed 2020·Granted Apr 26, 2022·1 cites·22 claims
- 0872US11969431B2Formulations for treatment of post-traumatic stress disorderGLYTECH LLC·Filed 2021·Granted Apr 30, 2024·0 cites·8 claims
- 0972US11013721B2Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorderSARAH HERZOG MEMORIAL HOSPITAL EZRAT NASHIM ASS·Filed 2019·Granted May 25, 2021·0 cites·14 claims
- 1072US9029410B2Pharmaceutical compositions for the treatment of movement disordersSARAH HERZOG MEMORIAL HOSPITAL EZRATH NASHIM ASS·Filed 2014·Granted May 12, 2015·2 cites·20 claims
- 1172US2009176715A1Pharmaceutical Compositions and Methods Utilizing a D-Amino AcidAMINO ACIDS SOLUTIONS INC·Filed 2009·Application pending·0 cites
- 1271US2022143041A1Combined therapy for nmdar antagonist-responsive neuropsychiatric disordersGLYTECH LLC·Filed 2022·Application pending·0 cites
- 1370US9737531B2Composition and method for treatment of depression and psychosis in humansJAVITT DANIEL C·Filed 2013·Granted Aug 22, 2017·1 cites·2 claims
- 1469US10583138B2Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2018·Granted Mar 10, 2020·0 cites·6 claims
- 1568US2022323435A1Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2022·Application pending·0 cites
- 1667US11576911B2Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2020·Granted Feb 14, 2023·0 cites·9 claims
- 1767US2024277728A1Formulations for treatment of post-traumatic stress disorderGLYTECH LLC·Filed 2024·Application pending·0 cites
- 1866US10660887B2Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2017·Granted May 26, 2020·0 cites·16 claims
- 1966US6162827ATreatment of negative and cognitive symptoms of schizophrenia with D-serineJAVITT DANIEL·Filed 1998·Granted Dec 19, 2000·19 cites·1 claims
- 2066US5854286ATreatment of negative and cognitive symptoms of schizophrenia with glycine and its precursorsJAVITT DANIEL C·Filed 1996·Granted Dec 29, 1998·24 cites·12 claims
- 2165US8629105B2Pharmaceutical compositions for the treatment of movement disordersHERESCO-LEVY URIEL·Filed 2003·Granted Jan 14, 2014·3 cites·9 claims
- 2263US2025009280A1System, method, and computer-accessible medium for determining possibility/likelihood of mental disorderUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 2360US10265278B2Pharmaceutical compositions and methods utilizing a D-amino acidAAS LLC·Filed 2017·Granted Apr 23, 2019·0 cites·2 claims
- 2460US6361957B1Assay for D-serine transport antagonist and use for treating psychosisGLYTECH INC·Filed 1999·Granted Mar 26, 2002·15 cites·8 claims
- 2560US2019054085A1Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2018·Application pending·0 cites
- 2658US6355681B2Glycine substitutes and precursors for treating a psychosisGLYTECH INC·Filed 1999·Granted Mar 12, 2002·16 cites·4 claims
- 2758US2018092881A1Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive DisorderSEROTECH LLC·Filed 2017·Application pending·0 cites
- 2858US2018028503A1Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive DisorderSEROTECH LLC·Filed 2017·Application pending·0 cites
- 2958US2018028504A1Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive DisorderSEROTECH LLC·Filed 2017·Application pending·0 cites
- 3058US2002183390A1D-serine transport antagonist for treating psychosisDANIEL JAVITT DR·Filed 2002·Application pending·0 cites
- 3157US9271966B2Pharmaceutical compositions for the treatment of movement disordersSARAH HERZOG MEMORIAL HOSPITAL EZRATH NASHIM ASS·Filed 2014·Granted Mar 1, 2016·0 cites·19 claims
- 3256US9789093B2Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorderHERESCO-LEVY URIEL·Filed 2012·Granted Oct 17, 2017·0 cites·12 claims
- 3356US2025302825A1Combination treatments for depression utilizing an nmdar antagonistGLYTECH LLC·Filed 2025·Application pending·0 cites
- 3455US2005159488A1D-serine transport antagonist for treating psychosisDANIEL JAVITT DR·Filed 2005·Application pending·0 cites
- 3555US2023096831A1System, method and computer-accessible medium for transcranial magnetic stimulation treatment of neuropsychiatric disordersUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 3655US2019240169A1Pharmaceutical compositions and methods utilizing a d-amino acidJAVITT DANIEL·Filed 2019·Application pending·0 cites
- 3754US11779218B2System, method and computer-accessible medium for predicting response to electroconvulsice therapy based on brain functional connectivity patternsUNIV COLUMBIA·Filed 2022·Granted Oct 10, 2023·0 cites·28 claims
- 3854US2002161048A1Glycine substitutes and precursors for treating a psychosisGLYTECH INC·Filed 2002·Application pending·0 cites
- 3947US2002010212A1Assay for D-serine transport antagonist and use for treating psychosisFiled 2001·Application pending·0 cites
- 4046US12502480B1System and method for administration of a substanceABUSARAH INC·Filed 2025·Granted Dec 23, 2025·0 cites·10 claims
- 4145US12097037B2System, method and computer-accessible medium for determining possibility/likelihood of mental disorderUNIV COLUMBIA·Filed 2018·Granted Sep 24, 2024·0 cites·46 claims
- 4245US2025144090A1Composition and method for treatment of depression and psychosis in humansGLYTECH LLC·Filed 2025·Application pending·0 cites
- 4344US11331041B2System, method and computer-accessible medium for predicting response to electroconvulsive therapy based on brain functional connectivity patternsUNIV COLUMBIA·Filed 2018·Granted May 17, 2022·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Daniel C. Javitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →